- Home
- NERV vs DLPN Comparison
NERV vs DLPN Comparison
Compare NERV & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- DLPN
- Stock Information
- Founded
- NERV 2007
- DLPN 1996
- Country
- NERV United States
- DLPN United States
- Employees
- NERV N/A
- DLPN N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- DLPN Other Consumer Services
- Sector
- NERV Health Care
- DLPN Consumer Discretionary
- Exchange
- NERV Nasdaq
- DLPN Nasdaq
- Market Cap
- NERV 12.4M
- DLPN 11.9M
- IPO Year
- NERV 2014
- DLPN N/A
- Fundamental
- Price
- NERV $1.84
- DLPN $1.18
- Analyst Decision
- NERV Hold
- DLPN Strong Buy
- Analyst Count
- NERV 1
- DLPN 1
- Target Price
- NERV $5.00
- DLPN $5.00
- AVG Volume (30 Days)
- NERV 15.2K
- DLPN 32.3K
- Earning Date
- NERV 08-05-2025
- DLPN 05-13-2025
- Dividend Yield
- NERV N/A
- DLPN N/A
- EPS Growth
- NERV N/A
- DLPN N/A
- EPS
- NERV 0.83
- DLPN N/A
- Revenue
- NERV N/A
- DLPN $48,618,803.00
- Revenue This Year
- NERV N/A
- DLPN $6.57
- Revenue Next Year
- NERV N/A
- DLPN $18.10
- P/E Ratio
- NERV $2.23
- DLPN N/A
- Revenue Growth
- NERV N/A
- DLPN 0.31
- 52 Week Low
- NERV $1.15
- DLPN $0.75
- 52 Week High
- NERV $3.69
- DLPN $2.22
- Technical
- Relative Strength Index (RSI)
- NERV 65.83
- DLPN 66.06
- Support Level
- NERV $1.75
- DLPN $1.02
- Resistance Level
- NERV $1.90
- DLPN $1.12
- Average True Range (ATR)
- NERV 0.12
- DLPN 0.07
- MACD
- NERV 0.04
- DLPN 0.01
- Stochastic Oscillator
- NERV 90.00
- DLPN 68.18
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About DLPN Dolphin Entertainment Inc.
Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.